Cited by 121Sleep and Wakefulness ResearchHIV Research and TreatmentSleep and related disorders

Sleep electroencephalogram delta-frequency amplitude, night plasma levels of tumor necrosis factor alpha, and human immunodeficiency virus infection.

Open access
Darko, D F, Miller, J C, Gallen, C, White, J, Koziol, J, Brown, S J, Hayduk, R, Atkinson, J H +2 more·1995·Proceedings of the National Academy of Sciences

Abstract

We tested the hypothesis that increases in tumor necrosis factor alpha (TNF-alpha) induced by human immunodeficiency virus (HIV) are associated with the increases in slow-wave sleep seen in early HIV infection and the decrease with sleep fragmentation seen in advanced HIV infection. Nocturnal sleep disturbances and associated fatigue contribute to the disability of HIV infection. TNF-alpha causes fatigue in clinical use and promotes slow-wave sleep in animal models. With slow progress toward a vaccine and weak effects from current therapies, efforts are directed toward extending productive life of HIV-infected individuals and shortening the duration of disability in terminal illness. We describe previously unrecognized nocturnal cyclic variations in plasma levels of TNF-alpha in all subjects. In 6 of 10 subjects (1 control subject, 3 HIV-seropositive patients with CD4+ cell number > 400 cells per microliters, and 2 HIV-positive patients with CD4+ cell number < 400 cells per microliters), these fluctuations in TNF-alpha were coupled to the known rhythm of electroencephalogram delta amplitude (square root of power) during sleep. This coupling was not present in 3 HIV-positive subjects with CD4+ cell number < 400 cells per microliters and 1 control subject. In 5 HIV subjects with abnormally low CD4+ cell counts ( < 400 cells per microliters), the number of days since seroconversion correlated significantly with low correlation between TNF-alpha and delta amplitude. We conclude that a previously unrecognized normal, physiological coupling exists between TNF-alpha and delta amplitude during sleep and that the lessened likelihood of this coupling in progressive HIV infection may be important in understanding fatigue-related symptoms and disabilities.

Integrity signals

Registry

Crossref · 10.1073/pnas.92.26.12080

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Cites

Flagged first, then by citations

Research works printed but not linked: 27

  1. Arditi M., Kabat W., Yogev R. Serum tumor necrosis factor alpha, interleukin 1-beta, p24 antigen concentrations and CD4+ cells at various stages of human immunodeficiency virus 1 infection in children. Pediatr Infect Dis J. 1991 Jun;10(6):450–455. doi: 10.1097/00006454-199106000-00007. [DOI] [PubMed] [Google Scholar] · DOI
  2. Armitage R., Roffwarg H. P., Rush A. J., Calhoun J. S., Purdy D. G., Giles D. E. Digital period analysis of sleep EEG in depression. Biol Psychiatry. 1992 Jan 1;31(1):52–68. doi: 10.1016/0006-3223(92)90006-l. [DOI] [PubMed] [Google Scholar] · DOI
  3. Banks W. A., Kastin A. J. Blood to brain transport of interleukin links the immune and central nervous systems. Life Sci. 1991;48(25):PL117–PL121. doi: 10.1016/0024-3205(91)90385-o. [DOI] [PubMed] [Google Scholar] · DOI
  4. Banks W. A., Ortiz L., Plotkin S. R., Kastin A. J. Human interleukin (IL) 1 alpha, murine IL-1 alpha and murine IL-1 beta are transported from blood to brain in the mouse by a shared saturable mechanism. J Pharmacol Exp Ther. 1991 Dec;259(3):988–996. [PubMed] [Google Scholar]
  5. Darko D. F., McCutchan J. A., Kripke D. F., Gillin J. C., Golshan S. Fatigue, sleep disturbance, disability, and indices of progression of HIV infection. Am J Psychiatry. 1992 Apr;149(4):514–520. doi: 10.1176/ajp.149.4.514. [DOI] [PubMed] [Google Scholar] · DOI
  6. Darko D. F., Mitler M. M., Henriksen S. J. Lentiviral infection, immune response peptides and sleep. Adv Neuroimmunol. 1995;5(1):57–77. doi: 10.1016/0960-5428(94)00044-o. [DOI] [PubMed] [Google Scholar] · DOI
  7. Feinberg I. Period/amplitude measures of delta show robust declines across nonrapid eye movement sleep episodes: a comment on Armitage and Roffwarg. Sleep. 1993 Dec;16(8):762–763. doi: 10.1093/sleep/16.8.762. [DOI] [PubMed] [Google Scholar] · DOI
  8. Glass J. D., Wesselingh S. L., Selnes O. A., McArthur J. C. Clinical-neuropathologic correlation in HIV-associated dementia. Neurology. 1993 Nov;43(11):2230–2237. doi: 10.1212/wnl.43.11.2230. [DOI] [PubMed] [Google Scholar] · DOI
  9. Jakubowski A. A., Casper E. S., Gabrilove J. L., Templeton M. A., Sherwin S. A., Oettgen H. F. Phase I trial of intramuscularly administered tumor necrosis factor in patients with advanced cancer. J Clin Oncol. 1989 Mar;7(3):298–303. doi: 10.1200/JCO.1989.7.3.298. [DOI] [PubMed] [Google Scholar] · DOI
  10. Krueger J. M., Dinarello C. A., Shoham S., Davenne D., Walter J., Kubillus S. Interferon alpha-2 enhances slow-wave sleep in rabbits. Int J Immunopharmacol. 1987;9(1):23–30. doi: 10.1016/0192-0561(87)90107-x. [DOI] [PubMed] [Google Scholar] · DOI
  11. Krueger J. M., Walter J., Dinarello C. A., Wolff S. M., Chedid L. Sleep-promoting effects of endogenous pyrogen (interleukin-1). Am J Physiol. 1984 Jun;246(6 Pt 2):R994–R999. doi: 10.1152/ajpregu.1984.246.6.R994. [DOI] [PubMed] [Google Scholar] · DOI
  12. Kubicki S., Henkes H., Alm D., Scheuler W., Pohle H. D., Ruf B., Könneke J. Schlafpolygraphische Daten von AIDS-Patienten. EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb. 1989 Dec;20(4):288–294. [PubMed] [Google Scholar]
  13. Kupfer D. J., Ehlers C. L., Frank E., Grochocinski V. J., McEachran A. B., Buhari A. Persistent effects of antidepressants: EEG sleep studies in depressed patients during maintenance treatment. Biol Psychiatry. 1994 May 15;35(10):781–793. doi: 10.1016/0006-3223(94)91140-1. [DOI] [PubMed] [Google Scholar] · DOI
  14. Lau A. S., Livesey J. F. Endotoxin induction of tumor necrosis factor is enhanced by acid-labile interferon-alpha in acquired immunodeficiency syndrome. J Clin Invest. 1989 Sep;84(3):738–743. doi: 10.1172/JCI114231. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  15. Maury C. P., Lăhdevirta J. Correlation of serum cytokine levels with haematological abnormalities in human immunodeficiency virus infection. J Intern Med. 1990 Apr;227(4):253–257. doi: 10.1111/j.1365-2796.1990.tb00154.x. [DOI] [PubMed] [Google Scholar] · DOI
  16. Norman S. E., Chediak A. D., Freeman C., Kiel M., Mendez A., Duncan R., Simoneau J., Nolan B. Sleep disturbances in men with asymptomatic human immunodeficiency (HIV) infection. Sleep. 1992 Apr;15(2):150–155. doi: 10.1093/sleep/15.2.150. [DOI] [PubMed] [Google Scholar] · DOI
  17. Norman S. E., Resnick L., Cohn M. A., Duara R., Herbst J., Berger J. R. Sleep disturbances in HIV-seropositive patients. JAMA. 1988 Aug 19;260(7):922–922. [PubMed] [Google Scholar]
  18. Odeh M. The role of tumour necrosis factor-alpha in acquired immunodeficiency syndrome. J Intern Med. 1990 Dec;228(6):549–556. doi: 10.1111/j.1365-2796.1990.tb00278.x. [DOI] [PubMed] [Google Scholar] · DOI
  19. Rautonen J., Rautonen N., Martin N. L., Philip R., Wara D. W. Serum interleukin-6 concentrations are elevated and associated with elevated tumor necrosis factor-alpha and immunoglobulin G and A concentrations in children with HIV infection. AIDS. 1991 Nov;5(11):1319–1325. doi: 10.1097/00002030-199111000-00006. [DOI] [PubMed] [Google Scholar] · DOI
  20. Roux-Lombard P., Modoux C., Cruchaud A., Dayer J. M. Purified blood monocytes from HIV 1-infected patients produce high levels of TNF alpha and IL-1. Clin Immunol Immunopathol. 1989 Mar;50(3):374–384. doi: 10.1016/0090-1229(89)90144-x. [DOI] [PubMed] [Google Scholar] · DOI
  21. Shibata M., Blatteis C. M. Human recombinant tumor necrosis factor and interferon affect the activity of neurons in the organum vasculosum laminae terminalis. Brain Res. 1991 Oct 25;562(2):323–326. doi: 10.1016/0006-8993(91)90639-d. [DOI] [PubMed] [Google Scholar] · DOI
  22. Shoham S., Davenne D., Cady A. B., Dinarello C. A., Krueger J. M. Recombinant tumor necrosis factor and interleukin 1 enhance slow-wave sleep. Am J Physiol. 1987 Jul;253(1 Pt 2):R142–R149. doi: 10.1152/ajpregu.1987.253.1.R142. [DOI] [PubMed] [Google Scholar] · DOI
  23. Voth R., Rossol S., Klein K., Hess G., Schütt K. H., Schröder H. C., Meyer zum Büschenfelde K. H., Müller W. E. Differential gene expression of IFN-alpha and tumor necrosis factor-alpha in peripheral blood mononuclear cells from patients with AIDS related complex and AIDS. J Immunol. 1990 Feb 1;144(3):970–975. [PubMed] [Google Scholar]
  24. Wesselingh S. L., Power C., Glass J. D., Tyor W. R., McArthur J. C., Farber J. M., Griffin J. W., Griffin D. E. Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann Neurol. 1993 Jun;33(6):576–582. doi: 10.1002/ana.410330604. [DOI] [PubMed] [Google Scholar] · DOI
  25. White J. L., Darko D. F., Brown S. J., Miller J. C., Hayduk R., Kelly T., Mitler M. M. Early central nervous system response to HIV infection: sleep distortion and cognitive-motor decrements. AIDS. 1995 Sep;9(9):1043–1050. doi: 10.1097/00002030-199509000-00009. [DOI] [PubMed] [Google Scholar] · DOI
  26. Wiedenmann B., Reichardt P., Räth U., Theilmann L., Schüle B., Ho A. D., Schlick E., Kempeni J., Hunstein W., Kommerell B. Phase-I trial of intravenous continuous infusion of tumor necrosis factor in advanced metastatic carcinomas. J Cancer Res Clin Oncol. 1989;115(2):189–192. doi: 10.1007/BF00397922. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  27. Wiegand M., Möller A. A., Schreiber W., Krieg J. C., Fuchs D., Wachter H., Holsboer F. Nocturnal sleep EEG in patients with HIV infection. Eur Arch Psychiatry Clin Neurosci. 1991;240(3):153–158. doi: 10.1007/BF02190756. [DOI] [PubMed] [Google Scholar] · DOI

Cited by

Sorted by citations

Authors
Darko, D. F., Miller, J. C., Gallen, C., White, J., Koziol, J., Brown, S. J., Hayduk, R., Atkinson, J. H., Assmus, J., & Munnell, D. T.
Affiliations
Scripps Research Institute (US)
Venue
Proceedings of the National Academy of Sciences
Published
1995-12-19
Volume
92
Issue
26
Pages
12080-12084
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2118624908
Cited by
121
References
8
Citations by year
2025: 3 · 2024: 1 · 2022: 2 · 2021: 1 · 2020: 3 · 2019: 2 · 2018: 3 · 2017: 4 · 2016: 3 · 2014: 2 · 2013: 7 · 2012: 10
FWCI
1.91
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (1r29mh042762-01a1, Z99 NS999999, RR00827, RR00833, MH47680, MH45294)
  • U.S. Navy
  • National Institute on Alcohol Abuse and Alcoholism
  • National Institute of Mental Health (P50MH047680, MH-42762)
  • National Institute of Neurological Disorders and Stroke
  • National Center for Research Resources (M01RR000833, M01RR000827)
  • U.S. Army Medical Research and Development Command
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
Keywords
HIV infection, TNF-α, sleep EEG, slow-wave sleep, CD4 count, seroconversion, fatigue, sleep fragmentation
MeSH terms
Adult, Animals, Delta Rhythm, HIV Seropositivity, Humans, Male, Reference Values, Sleep, Time Factors, Tumor Necrosis Factor-alpha, HIV Seronegativity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review